Johann Eibl
107Patents
20h-index
87Co-inventors
93Inventor score
Filing activity: Feb 13, 1974 → Dec 14, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4735616A | Arrangement for applying a tissue adhesive | Human Necessities | 338 | Expired |
| US4640834A | Method of inactivating reproducible filterable pathogens in blood products as well as a method of producing blood products | Human Necessities | 100 | Expired |
| US5608038A | Highly concentrated immunoglobulin preparation and method for its production | Human Necessities | 97 | Expired |
| US6224862A | Pharmaceutical preparation for treating blood coagulation disorders | Chemistry; Metallurgy | 74 | Expired |
| US6017891A | Stable preparation for the treatment of blood coagulation disorders | Chemistry; Metallurgy | 62 | Expired |
| US5714370A | Thrombin and method of producing the same | Human Necessities | 48 | Expired |
| US4276259A | Apparatus for performing a radioimmunological method of determining antigens or antibodies | Emerging Cross-Sectional Technologies | 39 | Expired |
| US5478093A | Surgical handpiece | Emerging Cross-Sectional Technologies | 37 | Expired |
| US7220569B2 | Nucleic acids encoding factor X analogues having a modified protease cleavage site | Human Necessities | 29 | Expired |
| US5304383A | Pharmaceutical preparation based on Lys-plasminogen | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5854403A | Method for isolation of highly pure von Willebrand Factor | Human Necessities | 28 | Expired |
| US4160025A | Method of producing a blood-coagulation-promoting preparation from human blood plasma | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5698677A | Stable preparation for the treatment of blood coagulation disorders | Chemistry; Metallurgy | 26 | Expired |
| US5122373A | Immunoglobulin-G-containing fraction | Human Necessities | 26 | Expired |
| US6228613A | Stable factor VIII/von Willebrand factor complex | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5866122A | Pharmaceutical preparation for treating blood coagulation disorders | Chemistry; Metallurgy | 24 | Expired |
| US5478558A | Method of dissolving venous Thrombi using drug containing activated Protein C | Chemistry; Metallurgy | 24 | Expired |
| US4687664A | Method of inactivating reproducible pathogens | Human Necessities | 23 | Expired |
| US4904641A | Method of inactivating reproducible filterable pathogens in blood plasma products | Human Necessities | 23 | Expired |
| US4395396A | Blood-coagulation-promoting preparation based on human proteins and a method of producing the same | Human Necessities | 22 | Expired |
| US6086871A | Prothrombin derivatives | Physics | 20 | Expired |
| US5776452A | Thrombosis agent | Chemistry; Metallurgy | 19 | Expired |
| US6210929A | Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequence | Chemistry; Metallurgy | 19 | Expired |
| US6005077A | Use of von willebrand factor and pharmaceutical formulation | Physics | 19 | Expired |
| US4946677A | Preparations active against pseudomonas aeruginosa infections and methods of producing them | Emerging Cross-Sectional Technologies | 18 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.